Dr Reddys Laboratories (RDY) EBT Margin Growth (3y) (2012 - 2023)
Dr Reddys Laboratories (RDY) EBT Margin Growth (3y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 1,282.00 |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 58.00 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | -861.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -1,020.00 |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | -995.00 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1,157.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | -4,603.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1,019.00 |
| Mar 31, 2023 | 778.00 |
| Jun 30, 2021 | 674.00 |
| Mar 31, 2021 | 163.00 |
| Sep 30, 2020 | -2,656.00 |
| Sep 30, 2019 | -599.00 |
| Mar 31, 2019 | 87.00 |
| Dec 31, 2018 | -78.00 |
| Sep 30, 2018 | -579.00 |
| Jun 30, 2018 | -756.00 |
| Dec 31, 2017 | -496.00 |
| Sep 30, 2017 | -673.00 |
| Dec 31, 2016 | -1,412.00 |
| Sep 30, 2016 | -552.00 |
| Mar 31, 2016 | 2,145.00 |
| Dec 31, 2015 | -808.00 |
| Sep 30, 2015 | -614.00 |
| Jun 30, 2015 | 62.00 |
| Dec 31, 2014 | -42.00 |
| Sep 30, 2014 | 2,259.00 |